Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OSE Immunotherapeutics
Biotech
BioNTech founders to pioneer new company—Chutes & Ladders
BioNTech founders will depart to pioneer new company. OSE makes interim CEO permanent. Ipsen adds former Alltrna CEO as North America leader.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Mar 13, 2026 8:30am
Boehringer axes MASH deal after OSE asset fails to show efficacy
Mar 2, 2026 2:16pm
Ose narrows focus to conserve cash at expense of wider pipeline
Dec 9, 2025 9:41am
AbbVie hands back phase 1 duties for inflammation drug to Ose
Dec 8, 2025 5:39am
Former CBER chief Peter Marks leaps to Lilly—Chutes & Ladders
Oct 10, 2025 8:30am